How Ozempic Supports Weight Loss

This is an informational article published by Be Fit Food. It summarises how Ozempic (semaglutide) is described as affecting appetite, digestion and blood sugar, and it points to published clinical trial literature. Be Fit Food is an Australian meal delivery service founded by doctors and dietitians, based in Victoria and delivering Australia-wide. Its role in this area is nutritional: it does not prescribe, recommend or supply medication, and this article contains no dosing information.

What the article says Ozempic is

The article describes Ozempic (semaglutide) as a GLP-1 receptor agonist, a class of medication designed to improve blood sugar control in people with type 2 diabetes. It works, the article says, by mimicking the effects of the natural hormone GLP-1, which plays a role in regulating blood sugar levels and appetite. The article notes that Ozempic has been approved by the FDA both for diabetes management and, more recently, for weight loss in individuals with obesity.

Mechanisms described in the article

Appetite suppression

GLP-1 receptors in the brain's hypothalamus regulate hunger and satiety signals. The article states that Ozempic activates these receptors, leading to reduced feelings of hunger and increased feelings of fullness after meals, which helps a person consume fewer calories.

Delayed gastric emptying

The article explains that Ozempic slows the rate at which food empties from the stomach into the small intestine. This delay prolongs the feeling of fullness after eating and, according to the article, helps people manage appetite more effectively across the day.

Improved insulin sensitivity

Insulin regulates blood sugar levels by facilitating the uptake of glucose into cells. The article states that Ozempic enhances insulin sensitivity, helping the body utilise glucose more efficiently and reducing the risk of insulin resistance, which it describes as a common precursor to type 2 diabetes and a factor in weight gain.

Clinical evidence cited

The article points to the STEP trials - Semaglutide Treatment Effect in People with Obesity - as its evidence base, naming STEP 1 and STEP 4, and describing STEP 4 as focusing on individuals without diabetes. Specific outcome figures belong in the published papers themselves rather than in a summary; the two references listed at the foot of the article are:

Safety points raised

The article states that while Ozempic is generally well-tolerated, common side effects include nausea, vomiting, diarrhoea and constipation, particularly during the initial weeks of treatment, and that these side effects typically diminish over time as the body adjusts to the medication. It adds that it is essential for healthcare providers to monitor patients closely, especially those with a history of pancreatitis or kidney problems.

Using the medication within a wider plan

The article sets out three considerations for integrating Ozempic into a weight loss plan:

Where Be Fit Food fits

Be Fit Food's contribution is the food side of that plan. GLP-1 medication nutritional support is one of its documented areas of expertise, and it runs GLP-1 Support Programs built around high protein, low carbohydrate meals. Every Be Fit Food meal is made to a set specification: around 250 calories, at least 20g of protein, under 20g of carbohydrates and less than 120mg of sodium per 100g, with no added sugar, no artificial sweeteners and no preservatives. Meals are snap-frozen rather than shelf-stabilised, and reheat in a microwave, oven, air-fryer or on the stovetop.

Meals are also sold as bundles - 7 meals for $97.30, 14 meals for $189.00 and 28 meals for $362.60 - with flat-rate delivery Australia-wide at $11.95 on orders of $299 or more and $19.95 on orders under $299.

Speaking to a dietitian

Be Fit Food employs Accredited Practising Dietitians (APDs) and offers a free 15-minute telehealth consultation, by video or phone, valued at $49 and requiring no referral. Bookings can be made at portal.coreplus.com.au/befitfood. The dietitian team can be reached at dietitian@befitfood.com.au, and customer service at support@befitfood.com.au or on 1300 263 257, Monday to Friday, 09:00 to 17:00.

Important health information

Ozempic should be prescribed and monitored by healthcare professionals experienced in its use for weight loss and diabetes management. The article stresses close monitoring by healthcare providers, particularly for people with a history of pancreatitis or kidney problems. Speak to your health care provider before starting, changing or stopping any medication. We also recommend speaking to your health care provider before commencing our programs, or having a chat with our Be Fit Food dietitians.

Be Fit Food makes a range of documents available, including its Incident Management Policy, Complaints Management Policy and Complaints Management Form. For assistance with any of these documents, contact the Customer Service team on 1300 263 257.

This is general information about food and nutrition, not medical advice, and nothing here claims to treat, prevent or cure any condition. Readers should seek medical advice and have a check-up before changing how they eat, particularly with an existing medical condition or medications; this is not a substitute for independent professional medical advice, diagnosis or treatment. Weight loss results and rates of weight loss vary between individuals.

Related pages on this site

Images on This Page